These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 38895818)
1. Apolipoprotein E4 interferes with lipid metabolism to exacerbate depression-like behaviors in 5xFAD mice. Gong Y; Li M; Liu M; Wu X; Li Y; Qin C; Zhang L Animal Model Exp Med; 2024 Jun; 7(3):347-361. PubMed ID: 38895818 [TBL] [Abstract][Full Text] [Related]
2. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice. Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877 [TBL] [Abstract][Full Text] [Related]
3. APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease. Lin AL; Parikh I; Yanckello LM; White RS; Hartz AMS; Taylor CE; McCulloch SD; Thalman SW; Xia M; McCarty K; Ubele M; Head E; Hyder F; Sanganahalli BG Neurobiol Dis; 2020 Jun; 139():104834. PubMed ID: 32173556 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation. Valencia-Olvera AC; Balu D; Faulk N; Amiridis A; Wang Y; Pham C; Avila-Munoz E; York JM; Thatcher GRJ; LaDu MJ Neurotherapeutics; 2023 Jul; 20(4):1120-1137. PubMed ID: 37157042 [TBL] [Abstract][Full Text] [Related]
5. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773 [TBL] [Abstract][Full Text] [Related]
6. Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction. Marottoli FM; Katsumata Y; Koster KP; Thomas R; Fardo DW; Tai LM ASN Neuro; 2017; 9(4):1759091417719201. PubMed ID: 28707482 [TBL] [Abstract][Full Text] [Related]
7. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition. Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358 [TBL] [Abstract][Full Text] [Related]
8. APOE4 genotype or ovarian hormone loss influence open field exploration in an EFAD mouse model of Alzheimer's disease. Taxier LR; Philippi SM; York JM; LaDu MJ; Frick KM Horm Behav; 2022 Apr; 140():105124. PubMed ID: 35101701 [TBL] [Abstract][Full Text] [Related]
9. The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha. Taxier LR; Philippi SM; York JM; LaDu MJ; Frick KM Neurobiol Aging; 2022 Apr; 112():74-86. PubMed ID: 35051676 [TBL] [Abstract][Full Text] [Related]
10. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3. Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668 [TBL] [Abstract][Full Text] [Related]
11. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. Youmans KL; Tai LM; Nwabuisi-Heath E; Jungbauer L; Kanekiyo T; Gan M; Kim J; Eimer WA; Estus S; Rebeck GW; Weeber EJ; Bu G; Yu C; Ladu MJ J Biol Chem; 2012 Dec; 287(50):41774-86. PubMed ID: 23060451 [TBL] [Abstract][Full Text] [Related]
12. Human apolipoprotein E4 modulates the expression of Pin1, Sirtuin 1, and Presenilin 1 in brain regions of targeted replacement apoE mice. Lattanzio F; Carboni L; Carretta D; Rimondini R; Candeletti S; Romualdi P Neuroscience; 2014 Jan; 256():360-9. PubMed ID: 24161275 [TBL] [Abstract][Full Text] [Related]
13. APOE4 homozygote females are resistant to the beneficial effects of 17β-estradiol on memory and CA1 dendritic spine density in the EFAD mouse model of Alzheimer's disease. Taxier LR; Philippi SM; Fleischer AW; York JM; LaDu MJ; Frick KM Neurobiol Aging; 2022 Oct; 118():13-24. PubMed ID: 35843109 [TBL] [Abstract][Full Text] [Related]
14. Modeling Mixed Vascular and Alzheimer's Dementia Using Focal Subcortical Ischemic Stroke in Human ApoE4-TR:5XFAD Transgenic Mice. Hayden EY; Huang JM; Charreton M; Nunez SM; Putman JN; Teter B; Lee JT; Welch A; Frautschy S; Cole G; Teng E; Hinman JD Transl Stroke Res; 2020 Oct; 11(5):1064-1076. PubMed ID: 32086779 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain. Teter B; LaDu MJ; Sullivan PM; Frautschy SA; Cole GM Neuroreport; 2016 Aug; 27(11):791-5. PubMed ID: 27281274 [TBL] [Abstract][Full Text] [Related]
16. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice. Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252 [TBL] [Abstract][Full Text] [Related]
17. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E ε4 disrupts oligodendrocyte differentiation by interfering with astrocyte-derived lipid transport. Mok KK; Yeung SH; Cheng GW; Ma IW; Lee RH; Herrup K; Tse KH J Neurochem; 2023 Apr; 165(1):55-75. PubMed ID: 36549843 [TBL] [Abstract][Full Text] [Related]
19. Extra-Hippocampal Learning Deficits in Young Apolipoprotein E4 Mice and Their Synaptic Underpinning. Har-Paz I; Roisman N; Michaelson DM; Moran A J Alzheimers Dis; 2019; 72(1):71-82. PubMed ID: 31561365 [TBL] [Abstract][Full Text] [Related]
20. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice. Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]